207940:KRX
Samsung Biologics Co Ltd
₩1,298,000.00
0.00%
(0.00) 1D
Oct 16, 3:30:22 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Mkt. cap
63.03T
Avg. vol.
49.67K
Volume
0.00
P/E ratio
28.28
52-wk high
₩1,973,600
52-wk low
₩1,110,460
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
Mkt. cap
63.03T
Avg. vol.
49.67K
Volume
0.00
P/E ratio
28.28
52-wk high
₩1,973,600
52-wk low
₩1,110,460
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
FXLeaders
·
31 minutes ago
Nasdaq and Dow Jones Futures Recover Ealy Monday Ahead of Meta, Tesla and SpaceX Earnings as Iran De-escalation Hopes Lift Sentiment
Traders Union
·
1 hour ago
Conor Sen: S&P on Hyperliquid frequently moves at 6 p.m. Sunday
www.tokenpost.com
·
40 minutes ago
S&P 500 Futures Rise 0.3% as Oil Near $110 Ahead of Earnings
Yahoo Finance UK
·
9 hours ago
Yardeni Lowers S&P 500 Target to 7,900 Despite Maintaining 2027 Earnings Forecast
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd